Cite
HARVARD Citation
Furugaki, K. et al. (n.d.). 3046 Impact of bevacizumab in combination with erlotinib on EGFRmutatant non-small cell lung cancer xenograft models with T790M mutation or MET amplification. European journal of cancer. pp. S611-S612. [Online].